Clinical Trial Update: Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

The document outlines a Phase 2 clinical trial evaluating first-line therapy with camrelizumab and chemotherapy, with or without anlotinib, for advanced gallbla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Gallbladder Cancer and Extrahepatic Cholangiocarcinoma | Phase 2 | Status: ENROLLING_BY_INVITATION